Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 1.23B 414M 362M 335M 312M 587M 39.14B 591M 3.98B 1.55B 19.24B 1.55B 1.52B 66.85B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.23B 414M 362M 335M 312M 587M 39.14B 591M 3.98B 1.55B 19.24B 1.55B 1.52B 66.85B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.92x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 64 24/12/2019
Chairman 77 07/03/2013
Director/Board Member 75 13/12/1990
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.28% - - 414M
+0.42%-0.40%+20.16%-21.46% 62.32B
+0.69%-0.28%+51.64%+197.92% 53.94B
-5.75%+29.50%+29.50%+29.50% 38.98B
-0.74%+5.45%-53.47%-60.27% 37.89B
+1.59%+0.54%+57.20%-32.06% 29.48B
-7.22%+13.84%+129.13%-50.74% 23.55B
+5.54%+1.65%+51.42%+67.44% 20.71B
+1.59%+0.13%-3.04%+151.23% 16.71B
+2.25%+5.86%+64.60%+119.04% 16.02B
Average -0.22%+1.40%+38.57%+44.51% 33.29B
Weighted average by Cap. -0.45%+0.63%+33.18%+39.70%

Financials

2026 *2027 *
Net sales 585M 197M 172M 159M 148M 278M 18.57B 280M 1.89B 734M 9.13B 738M 722M 31.72B 642M 216M 189M 174M 163M 306M 20.39B 308M 2.07B 806M 10.02B 810M 792M 34.82B
Net income 72.01M 24.2M 21.15M 19.56M 18.26M 34.28M 2.29B 34.53M 232M 90.45M 1.12B 90.87M 88.9M 3.91B 104M 34.84M 30.44M 28.16M 26.28M 49.33M 3.29B 49.7M 335M 130M 1.62B 131M 128M 5.62B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!